Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment

Journal of the European Academy of Dermatology and Venereology

Volumn 14, Issue 5, 2000, Pages 382-388

  Haustein, U F ^a   Rytter, M ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Efficacy; Long term treatment; Methotrexate; Psoriasis; Safety; Side effects

Indexed keywords

FOLINATE CALCIUM; METHOTREXATE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INTERACTION; DRUG OVERDOSE; DRUG SAFETY; DRUG SCREENING; EXPERIENCE; FEMALE; FOLLOW UP; GERMANY; HAIR LOSS; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TOXICITY; LONG TERM CARE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAUSEA; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; SENESCENCE; SIDE EFFECT; SKIN NECROSIS; STOMACH DISEASE; SUICIDE; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0034426611     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2000.00058.x     Document Type: Article

References (32)

1. Therapeutic suppression of tissue reactivity: Effect of aminopterin in rheumatoid arthritis and psoriasis
2. Treatment of psoriasis with folic acid antagonist
3. Guidelines on methotrexate therapy for psoriasis
4. Methotrexate in psoriasis: Revised guidelines
5. Methotrexate therapy of psoriasis: Differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate
6. Methotrexate induces apoptotic cell death in human keratinocytes
7. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leucocyte accumulation in an in vivo model of inflammation
8. Methotrexate for psoriasis: A new therapeutic schedule
9. Differences in the biochemical activity in hairless mouse skin and other organs after systemic and topical methotrexate treatment
10. Methotrexat-Blutspiegel nach oraler und intravenöser Applikation
11. Serum type III collagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients
12. Rotational approach to therapy for moderate to severe psoriasis
13. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis
14. Methotrexate: Bioavailability and pharmacokinetics
15. Acitretin in psoriasis: An update
16. Grossflächige erosiv-hämorrhagische Läsionen in psoriatischen Plaques infolge Methotrexatin-toxikation
17. Drug interactions with methotrexate
18. Effect of low-dose methotrexate on the disposition of glucocorticosteroids and theophylline
19. Methotrexate in psoriasis: Consensus conference
20. Dipyridamole potentiates in growth-inhibitory action of methotrexate and 5-fluorouracil in human keratinocytes in vitro
21. Langjährige Erfahrungen mit der Methotrexatbehandlung von komplizierten Formen der Psoriasis
22. Methotrexat in der Dermatologie - Klinischer Erfahrungsbericht über 25 Jahre
23. Methotrexate the conservative treatment for psoriasis
24. Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate
25. Methotrexate
26. Methotrexate revisited: Effects of long-term treatment in psoriasis
27. Methotrexate side-effects
28. Psoriasis therapy and the risk of skin cancers
29. Reduced folate carrier (RFC-1) gene expression in normal and psoriatic skin
30. Erosion of psoriatic plaques: An early sign of methotrexate toxicity
31. Methotrexate-induced liver cirrhosis. A follow up
32. The impact of methotrexate on psycho-organic functioning